[18f]alf-resca-il2
Recombinant proteinexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2022 (NCT05471271)
Timeline
No events for the selected filters.
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05471271 | N/A | Dec 31, 2022 | University of Groningen |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Groningen | Academic/Hospital | 1 | 1 | 1 | 2022 |
1 organizations
Page 1 / 1